Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...
With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
MOMENTUM 3 Study meets primary endpoint for short-term indication Results presented during late-breaking clinical trial session at the AHA Scientific Sessions MOMENTUM 3 Study data published in the ...
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...
Pediatric ventricular assist devices (VADs) and mechanical circulatory support systems have emerged as critical tools in the management of children with end‐stage heart failure, including those with ...
The DuraHeart Left-Ventricular Assist System, or “LVAS,” from Terumo Heart was featured at a recent health technology event. DuraHeart LVAS is a next-generation medical device designed to help sustain ...
Ventracor Limited (ASX:VCR) today announced the first European implant of its leading heart assist system. Ventracor Chief Executive Officer, Colin Sutton PhD, said "Surgeons at Papworth Hospital in ...
Hundreds of HeartMate 3 left ventricular assist device (LVAD) systems are being recalled due to reports of blood leakage or air entering the seal interface between the device inflow cannula and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results